Diabetes, Obesity & Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. "Metabolism" may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 5.4 |
| 2022 | NA |
| 2021 | NA |
DIABETES OBESITY & METABOLISM, 1463-1326, 1999-ongoing, Biochemistry, Genetics and Molecular Biology,Medicine.